S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits
about
Vascular biology of eicosanoids and atherogenesisMicrovascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV.Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic stTP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis.Antagonism of thromboxane receptors by diclofenac and lumiracoxibAntiplatelet drugs in cardiological practice: established strategies and new developmentsControversies and future perspectives of antiplatelet therapy in secondary stroke preventionEicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolismExpansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies.Lipoxygenase and prostaglandin G/H synthase cascades in cardiovascular disease.Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis.Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.Targeted Treatments for Restenosis and Vein Graft Disease
P2860
Q28259045-C10944C9-5344-4C22-A49A-6F038B3785E3Q33792101-B62020A1-9E77-43DD-B1F9-CF1383394DB8Q33920331-DB61E682-7C1A-4541-813E-0C46B1248A9DQ34415503-7D44CB31-9F45-41FC-A1EA-A9C5D6B569A8Q36358638-D8F511B6-8C63-4DE3-BCF4-DF445B43CDADQ36835862-0345A684-0AB5-47D0-AEE8-118626ADA0C6Q37782412-139B4D1C-BB85-4DE2-A060-54249A955E9AQ37995534-CF3F3C72-C949-46E3-B880-E99F0BB21A89Q38525064-3498B08E-67F2-4DEC-BD74-E312EED80951Q39274427-2EC11E79-00F7-44F2-B2D3-B034DEAF3C54Q41533935-C15F8C2B-E3EF-4E39-B9E7-227B735F76D4Q43061580-2AD83BD7-D47A-4209-B731-E0EB20B484E6Q45145010-2FB48FF5-43E2-42F3-953D-49B0AE7AC865Q47385143-C7CD18BD-B725-4E2E-B299-735677FD9909Q58691736-0B23522E-A58C-4065-8905-1F3BD9E5756C
P2860
S18886, a selective TP receptor antagonist, inhibits development of atherosclerosis in rabbits
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@ast
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@en
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@nl
type
label
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@ast
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@en
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@nl
prefLabel
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@ast
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@en
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@nl
P2093
P1433
P1476
S18886, a selective TP recepto ...... of atherosclerosis in rabbits
@en
P2093
Celia L Berry
Julie H Campbell
Nathalie F Worth
P356
10.1016/J.ATHEROSCLEROSIS.2005.02.034
P407
P577
2005-11-01T00:00:00Z